Company Filing History:
Years Active: 2025
Title: The Innovations of Phillip Lichtor
Introduction
Phillip Lichtor is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical conditions.
Latest Patents
Lichtor holds a patent for 2,6,9-trisubstituted purines. This patent includes compounds having the structure of Formula (I) and pharmaceutically acceptable salts thereof. The patent outlines the use of these compounds and salts to treat or prevent cyclin-dependent kinase 2 (CDK2)-mediated conditions. It also covers pharmaceutical compositions comprising such compounds and salts, kits that include these compounds, and methods for manufacturing them.
Career Highlights
Phillip Lichtor has had a distinguished career, working with AstraZeneca AB, a leading global biopharmaceutical company. His work has focused on innovative solutions in drug development, contributing to advancements in medical treatments.
Collaborations
Lichtor has collaborated with esteemed colleagues such as Bernard Barlaam and Michael Steven Bodnarchuk. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Phillip Lichtor's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His work continues to impact the field positively, showcasing the importance of innovation in healthcare.